Impel
is a Washington-based biopharmaceutical company that develops and commercializes nasal drug delivery therapeutics for the treatment of CNS disorders... Read moreImpel
is a Washington-based biopharmaceutical company that develops and commercializes nasal drug delivery therapeutics for the treatment of CNS disorders... Read more
News
Apr 05, 2024
PRWeb
Press Release: Impel : IPI Legacy Liquidation Co., Formerly Known as Impel Pharmaceuticals, Announces Confirmation and Effective Date of Joint Plan of Liquidation
Feb 14, 2024
Owler
Impel Neuropharma, Inc.: Impel's revenue changed from $19.05M in Jun 2023 to $20.99M in Sep 2023
Aug 18, 2023
Owler
Impel Neuropharma, Inc.: Impel's revenue changed from $15.27M in Mar 2023 to $19.05M in Jun 2023
May 12, 2023
Owler
Impel Neuropharma, Inc.: Impel's revenue changed from $12.65M in Dec 2022 to $15.27M in Mar 2023
Mar 28, 2023
Owler
Impel Neuropharma, Inc.: Impel's employee count changed from 133 in Dec 2021 to 160 in Dec 2022
Nov 15, 2022
Owler
Impel Neuropharma, Inc.: Impel's revenue changed from $5.23M in Jun 2022 to $8.22M in Sep 2022
Aug 15, 2022
Zacks
Impel: Impel Pharmaceuticals Inc. (IMPL) Reports Q2 Loss, Tops Revenue Estimates
May 16, 2022
Owler
Impel Neuropharma, Inc.: Impel's revenue changed from 668K in Dec 2021 to 914K in Mar 2022
Apr 26, 2022
Drug Delivery Business
Impel: Impel NeuroPharma rebrands to Impel Pharmaceuticals as part of corporate transformation
Apr 21, 2022
centralcharts
Press Release: Impel : Impel NeuroPharma to Ring Nasdaq Closing Bell on Monday, April 25
Impel Competitors
1
2
3
4
5
6
7
8
9
10